Benzinga - Tue, 20 Apr 2021 12:45:04 -0400
Benzinga - Tue, 20 Apr 2021 04:56:52 -0400
Benzinga - Mon, 19 Apr 2021 05:19:22 -0400
Benzinga - Fri, 16 Apr 2021 13:39:27 -0400
Benzinga - Fri, 16 Apr 2021 13:00:36 -0400
Benzinga - Mon, 22 Mar 2021 03:27:06 -0400
Benzinga - Fri, 19 Mar 2021 12:16:51 -0400
Benzinga - Thu, 18 Mar 2021 09:17:58 -0400
Benzinga - Fri, 05 Mar 2021 06:37:42 -0400
Benzinga - Mon, 22 Feb 2021 05:59:48 -0400
Benzinga - Fri, 19 Feb 2021 15:00:11 -0400
load more
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV
Q4 2020Est.ActualSurprise
EPS
REV

Related Companies

TickerCompanyChg %Mkt Cap
PRFXPainReform2.63%27.5M

PainReform Company Questions & Answers

Q

How do I buy PainReform (PRFX) stock?

A

You can purchase shares of PainReform (NASDAQ: PRFX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PainReform's (PRFX) main competitors?

A

There are no as such competitors for PainReform.

Q

What is the target price for PainReform?

A

There is no analysis for PainReform

Q

How much is PainReform (PRFX) stock ?

A

The stock price for PainReform (NASDAQ: PRFX) is $2.73 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next PainReform (PRFX) dividend?

A

There are no upcoming dividends for PainReform.

Q

When is PainReform (NASDAQ:PRFX) reporting earnings?

A
PainReform’s Q2 earnings are confirmed after-market from now on August 8, 2021.
Q

When is the upcoming split for PRFX?

A

There is no upcoming split for PainReform.